The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain ...

The ERVI is reviewing the EU's production capacity for metallic HALEU. It is also looking at ways to enhance the production ...

Jon Ellis and Simon Vanstone, PhD, go behind the headlines to explore the latest M&A activity and what tariffs and funding changes could mean for mRNA and beyond.

As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.